Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy

por Maddur, Mohan S., Stephen-Victor, Emmanuel, Das, Mrinmoy, Prakhar, Praveen, Sharma, Varun K., Singh, Vikas, Rabin, Magalie, Trinath, Jamma, Balaji, Kithiganahalli N., Bolgert, Francis, Vallat, Jean-Michel, Magy, Laurent, Kaveri, Srini V., Bayry, Jagadeesh
Publicado 2017